Schlaich MP - Search Results

1

Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Böhm M, Krum H. Sobotka PA, et al. Among authors: schlaich mp. Clin Res Cardiol. 2011 Dec;100(12):1049-57. doi: 10.1007/s00392-011-0335-y. Epub 2011 Jun 19. Clin Res Cardiol. 2011. PMID: 21688196 Free PMC article.

2

Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.

Schlaich MP, Lambert EA, Sobotka PA, Lambert GW, Esler MD. Schlaich MP, et al. Hypertension. 2007 May;49(5):e27; author reply e28. doi: 10.1161/HYPERTENSIONAHA.107.087908. Epub 2007 Mar 5. Hypertension. 2007. PMID: 17339531 No abstract available.

3

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Krum H, et al. Lancet. 2009 Apr 11;373(9671):1275-81. doi: 10.1016/S0140-6736(09)60566-3. Epub 2009 Mar 28. Lancet. 2009. PMID: 19332353 Clinical Trial.

4

Renal sympathetic-nerve ablation for uncontrolled hypertension.

Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Schlaich MP, et al. N Engl J Med. 2009 Aug 27;361(9):932-4. doi: 10.1056/NEJMc0904179. N Engl J Med. 2009. PMID: 19710497 No abstract available.

5

Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.

Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Schlaich MP, et al. Hypertension. 2009 Dec;54(6):1195-201. doi: 10.1161/HYPERTENSIONAHA.109.138610. Epub 2009 Oct 12. Hypertension. 2009. PMID: 19822798 Review. No abstract available.

6

Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.

Schlaich MP, Krum H, Sobotka PA. Schlaich MP, et al. Curr Hypertens Rep. 2010 Feb;12(1):39-46. doi: 10.1007/s11906-009-0078-6. Curr Hypertens Rep. 2010. PMID: 20425157 Review.

7

New therapeutic approaches to resistant hypertension.

Schlaich MP, Krum H, Esler MD. Schlaich MP, et al. Curr Hypertens Rep. 2010 Aug;12(4):296-302. doi: 10.1007/s11906-010-0119-1. Curr Hypertens Rep. 2010. PMID: 20509010 Review.

8

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Symplicity HTN-2 Investigators; Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Symplicity HTN-2 Investigators, et al. Among authors: schlaich mp. Lancet. 2010 Dec 4;376(9756):1903-9. doi: 10.1016/S0140-6736(10)62039-9. Epub 2010 Nov 17. Lancet. 2010. PMID: 21093036 Clinical Trial.

9

Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system.

Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Krum H, et al. Circulation. 2011 Jan 18;123(2):209-15. doi: 10.1161/CIRCULATIONAHA.110.971580. Circulation. 2011. PMID: 21242507 Free article. Review. No abstract available.

10

Novel procedure- and device-based strategies in the management of systemic hypertension.

Krum H, Schlaich M, Sobotka P, Scheffers I, Kroon AA, de Leeuw PW. Krum H, et al. Eur Heart J. 2011 Mar;32(5):537-44. doi: 10.1093/eurheartj/ehq457. Epub 2011 Jan 18. Eur Heart J. 2011. PMID: 21247927 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters